Immediate Impact
2 by Nobel laureates 2 from Science/Nature 65 standout
Citing Papers
Polymeric Nanoparticles for Drug Delivery
2024 Standout
The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy
2023 Standout
Works of W. S. Dalton being referenced
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| W. S. Dalton | 171 | 61 | 211 | 6 | 322 | |
| Deepa Nachagari | 88 | 62 | 164 | 8 | 324 | |
| Aksana Vasilyeva | 129 | 22 | 120 | 11 | 291 | |
| Miguel A. Villalona | 191 | 50 | 190 | 8 | 342 | |
| P O'Connell | 123 | 55 | 70 | 11 | 347 | |
| Eric Marthinet | 183 | 39 | 142 | 7 | 314 | |
| Misako Ichikawa | 154 | 74 | 293 | 8 | 369 | |
| Kanyalakshmi Ayyanar | 214 | 31 | 82 | 10 | 347 | |
| Aniska A. Chhatta | 92 | 40 | 166 | 9 | 334 | |
| C. Tyler Kirkland | 85 | 35 | 109 | 6 | 285 | |
| Victoria Ling | 141 | 18 | 138 | 11 | 263 |
All Works
Loading papers...